Cite Filings / ELDN / 0002012383-26-000664
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Eledon Pharmaceuticals, Inc. · Filed 2026-01-21 · Acc 0002012383-26-000664

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2026-02-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-01-21 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-01-16 4 Director acquired 3,430 shares (option exercise)
  • 2026-01-16 4 Director acquired 3,430 shares (option exercise)
  • 2026-01-16 4 Director acquired 8,575 shares (option exercise)
  • 2026-01-16 4 Director acquired 3,430 shares (option exercise)
  • 2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…